Q301--NGS Malignancy Testing
VETERANS AFFAIRS, DEPARTMENT OF
Notice type
Sources Sought
Solicitation #
36C25026Q0709
NAICS
621511
PSC
Q301
Posted
July 9, 2026
Response due
July 14, 2026
Place of performance
Indianapolis, IN
What this opportunity is
The Department of Veterans Affairs is buying Next Generation Sequence (NGS) complex specialized testing and IHC testing and analysis of patient specimens, which suits businesses classified under NAICS 621511. This Sources Sought notice indicates that the government is gathering information from potential contractors, rather than soliciting bids, so interested businesses should track this opportunity for future developments.
Analysis by Mindy, grounded in the SAM.gov notice.
Description
DRAFT
STATEMENT OF WORK
Introduction:
The Richard L Roudebush VA Medical Center (VAMC) requires a contract for Hematologic
Malignancy Next Generation Sequence (NGS) complex specialized testing and IHC testing and
analysis of patient specimens.
Background:
The VA National Precision Oncology Program (NPOP) initially covered the cost of this testing.
Due to an evaluation nationally the NPOP may not cover repeat testing of NGS. For this reason,
a Task Order needs to be available for the Hematology providers to obtain a repeat NGS for
patients with changes in their diagnosis. Due to this change the Richard L Roudebush VAMC
has determined that the testing plays an important role in providing quality care and diagnoses to
the Veteran patient population.
NGS testing is an advanced test methodology at the gene level for detecting various forms of
diseases through patient blood specimens. It assists in diagnosing and developing treatment
plans for conditions such as, but not limited to many types of cancer, heart disease and
neurological diseases. The test can be specifically targeted for one or a multiple number of genes.
Results from targeted tests can not only guide care for patients but also guide family members as
well for specific therapies and other matters. NGS testing can examine over 20,000 genes.
Objective:
Maintain a high level of direct patient care with consistent testing methodology and results
reporting that will assist in developing treatment plans.
Period of Performance:
One year.
Scope:
1. Contractor shall provide specimen collection kits.
2. Contractor shall provide transport kits for use of transporting specimen tests in a safe
manner.
3. Contractor shall provide appropriate shipping labels for UPS in accordance with the
Department of Transportation (DOT) guidelines.
4. Contractor shall provide a portal for online test ordering.
5. VAMC accession numbers (VA identification number of order) and the contractor order
number assigned shall be used as the common references for tracking tests on all
documents.
6. Contractor policies and procedures, and employees shall comply with Health Insurance
Portability and Accountability Act (HIPPA).
7. Contractor service personnel shall be accessible by telephone or email at all times.
8. Contractor shall only accept and perform tests that are ordered by VAMC authorized
personnel listed in this contract.
-- 1 of 4 --
DRAFT
Contractor Requirements & Responsibilities:
1) Supplies:
a) Contractor shall contact the COR within five (5) business days following award to
coordinate the furnishing and delivery of all supplies, transportation supplies,
collection supplies.
b) Contractor shall provide written instructions for sample preparation, collection, and
transportation of all specimens.
c) Contractor shall provide the following supplies, and are not limited to:
i) Leak-proof plastic tubes and containers for routine shipment of diagnostic
specimens.
ii) Transportation labels and packaging supplies.
2) Procedure Guidelines:
a) Contractor shall have controls in place to be a certified laboratory per the regulatory
agencies of the VA.
b) Contractor shall ensure that all procedures performed are of current acceptable
standard deviation with at least (minimum) daily controls conducted to determine
procedure accuracy i. Upon request of the Contracting Officer Representative
(COR) or Contracting Officer (CO), Contractor shall provide the requested quality
assurance information on specific testing procedures.
c) Tests referred to another laboratory shall be at no additional transfer charge or
confirmation charge to the Government.
d) Contractor shall, whenever applicable or relevant, make a distinction between tests
that are FDA approved versus research only use (ROU), invitro diagnostic (IVD),
investigational use only (IUO), life science research (LSR), or emergency use
authorization (EAU).
i) In such cases, the distinction shall be printed on each result sheet.
3) Test Results: a. Primary reporting shall be via retrieval of results from the Contractors
secure website.
a) If the Contractors website is down, all reporting shall be faxed to 317-988-4146.
b) Contractor shall provide a shipping service for transport of samples to the testing
facility. i. Contractor shall deliver samples to the testing facility within the allowable
time limits placed by the VAMC.
i) The allowable time limit is 3 days as required by the VA.
ii) If the sample arrives past the required 3 days, the sample is no longer
usable.
c) Contractor shall provide test results to the ordering facility in accordance with the
testing specifications as defined in the Contractor’s commercial specimen
collection guide. i. Testing requiring a turnaround time (TAT) longer than 14 days
shall be identified by the Contractor before contract award and shall be approved
and listed this Statement of Work by the Contracting Officer.
d) Reporting of Results: A report is defined as a printed final copy of Next Generation
Sequencing laboratory testing results, which shall include the Mutation Allele
Frequency Report (MAF).
i) This report shall be received electronically through the contractor’s secure
website or faxed if the contractor website is down. 1. If the results of a test
are reported via telephone, the electronic report shall state the name of the
individual notified of the results.
-- 2 of 4 --
DRAFT
ii) Each report shall contain at minimum:
(1) Patient’s name
(2) Birth Date, Gender, and Age
(3) Contractor Order Number
(4) VAMC Accession Number
(5) Provider Name (if specified on the order)
(6) Medical Record Number (if specified on the order)
(7) Account Information
(8) Specimen Type
(9) Test Indication
(10) Mutations Detected
(11) Interpretation
(12) Facility Name
(13) Date/time specimen was received in the Reference Lab
(14) Reference Range if applicable per regulatory guidelines
(15) Name of testing laboratory and address (Contractor and/or
Subcontractor)
(16) Any additional comments related…
Source: SAM.gov, as posted. Verify the current solicitation before responding.
Pursue this opportunity with Mindy
See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.
View the original notice on SAM.gov ↗Similar Active Opportunities (NAICS 621511)
VA NWIHCS Pathology Service
VETERANS AFFAIRS, DEPARTMENT OF · Sources Sought · due August 3, 2026
Genotyping Analysis Services
DEPT OF DEFENSE · Solicitation · due July 30, 2026
Missouri State Newborn Testing
DEPT OF DEFENSE · Solicitation · due July 29, 2026
Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Solicitation · due July 27, 2026
Q301--Microbiological Testing
VETERANS AFFAIRS, DEPARTMENT OF · Special Notice · due July 22, 2026
Q301--Intent to Sole Source Specialized laboratory medical testing services
VETERANS AFFAIRS, DEPARTMENT OF · Special Notice · due July 24, 2026